Library
The Oncology Business Dynamics training library is designed with oncology stakeholders in mind, from commercial and medical teams at pharma, to providers and administrators at practices.
Modulettes
We came up with the term “modulette” to describe our succinct, bite-sized online learning modules that require less of a time investment. By narrowing the topic, and going deep into that singular topic, our modulettes provide a more enriching learning experience in a shorter period of time. Our library of 50+ modulettes is constantly updated, very interactive, fully referenced, and can be accessed on your LMS or ours. To make our library more navigable, you will see below that we’ve broken the modulettes into themes/categories.
Value-Based Care
-
Details the Enhancing Oncology Model, a CMS value-based payment program, which aims to shift federal oncology reimbursement away from fee-for-service care
-
Provides an overview of episode-based payment models piloted in oncology care
-
Provides a detailed view of the IRA, including how drug prices are negotiated and how the law impacts the delivery of cancer care
-
Details MACRA and the Quality Payment Program as part of the shift towards performance-adjusted payments and away from fee-for-service payments
-
Details key information on ACOs, helping providers understand the advantages and disadvantages of different ACO structures
-
Details the value-based Oncology Medical Home (OMH) payment model
-
Exploration of the term “quality” in the delivery of cancer care, and how it helps identify value based, versus volume based, models of cancer care
-
Outlines the shift to value-based care, explores care frameworks and reimbursement strategies that consider patients' outcomes
-
Explains the various incentive-based payment programs that are moving providers and healthcare teams from fee-for-service to value-based healthcare
The Landscape
-
Outlines how evidence and consensus among experts is used to guide oncology care
-
Discusses the development and use of clinical guidelines to treat cancer patients
-
Defines the term “financial toxicity” and how it applies to patients with cancer
-
Explains the basics of a joining a GPO, the contracting process, and benefits for providers
-
Provides key information on the formation of IDNs
-
Explains the basics of MCOs and roles of key decision makers
-
Defines the various terms used in cancer drug pricing and physician-administered drug reimbursement
-
Provides basic knowledge on the two government-sponsored payment programs
Innovations
Medicare, Medicaid, and Commercial Payers
-
Explanation of how insurers use these strategies to shift the cost of drugs to manufacturers and patients
-
Explains the basics of MCOs and roles of key decision makers
-
A deep dive into Medicare infrastructure, including an explanation of how Medicare reimbursement works across different settings
-
Details the process for reimbursing services covered under Medicare Part B
-
Explains this unique coverage for Medicare beneficiaries that provides an alternative to Parts A and B
-
Explores the dynamics of Medicare Part D prescription drug programs
-
Details tactics payers use to manage utilization of drugs and how payers use PBMs to contain costs and the impact this can have on patients
-
Provides basic knowledge on the two government-sponsored payment programs
Business of Healthcare 2.0
-
Provides an overview of current cancer statistics including incidence rates, treatments, and disparities in care
-
Defines and explains how implicit bias influences prescribing habits
-
Examines the impact of the cost of cancer care on individual patients and society at large
-
An introduction to basic oncology concepts and terms ie disease setting, staging, and therapeutics while also explaining clinical development and commercialization
-
Explores the larger trends affecting oncology practices and how they treat cancer patients today
-
Provides an in-depth review of enrollment in, and drug reimbursement through, the federal 340B program
-
Explanation of how insurers use these strategies to shift the cost of drugs to manufacturers and patients
-
Explains the terms end-of-life care and advanced-care planning, as well as the differences between palliative care and hospice care
-
Follows an outpatient specialty drug used to treat cancer from manufacturer to treatment, and how its use impacts manufacturers, payers and patients along the way
-
Follows a physician-administered drug used in cancer through the pharmaceutical supply chain, including Medicare Part B's impact on reimbursement for patients and providers
-
Explains how data collected after the clinical trial process is used by payers and providers to guide decision-making
-
Provides a detailed view of the IRA, including how drug prices are negotiated and how the law impacts the delivery of cancer care
-
Expalins CMS-approved compendia and off-label use
-
Details tactics payers use to manage utilization of drugs and how payers use PBMs to contain costs and the impact this can have on patients
-
Exploration of the term “quality” in the delivery of cancer care, and how it helps identify value based, versus volume based, models of cancer care
-
Provides a high-level overview of VA and DoD policies and compares them with community care strategies
-
Defines the terms and what they mean in the distribution process of drugs used in cancer care
Patient Focused
-
Provides an overview of current cancer statistics including incidence rates, treatments, and disparities in care
-
Explanation of how insurers use these strategies to shift the cost of drugs to manufacturers and patients
-
Defines the term “financial toxicity” and how it applies to patients with cancer
-
An overview of the cancer patient’s journey from the perspective of, and impact on, providers
-
An overview of strategies to understand, and cope with, grief as a result of death
Business of Healthcare 1.0
Community Practice Management
-
Defines the term “financial toxicity” and how it applies to patients with cancer
-
Defines and explains how implicit bias influences prescribing habits
-
Cancer patient management is unique because it involves so many specialties. This modulette explains how the care team works together to manage the patient.
-
Provides a look inside an oncology practice and how it functions, including how patients are administered care and how costs are managed
-
An overview of the cancer patient’s journey from the perspective of, and impact on, providers
-
An overview of strategies to understand, and cope with, grief as a result of death
Oral Therapies
-
Follows an outpatient specialty drug used to treat cancer from manufacturer to treatment, and how its use impacts manufacturers, payers and patients along the way
-
Explores the dynamics of Medicare Part D prescription drug programs
-
Discusses the role of internal pharmacy dispensing and how it may reduce costs for providers
-
Outlines the specialty drug marketplace and how SPPs help patients and providers access specialty drugs
-
Defines the terms and what they mean in the distribution process of drugs used in cancer care
-
Details how novel technologies and research techniques are improving cancer care
-
Examines how big data and artificial intelligence is being harnessed to improve cancer care
-
Provides key information on the benefits of electronic health records, especially in relation to quality reporting and the shift to value-based care
-
Explains what a biosimilar drug is and the reimbursement policies that surround them
-
Provides and in-depth look into the burgeoning field of precision medicine in oncology, including the use of small molecules, monoclonal antibodies, and immune checkpoint inhibitors
Outliers
-
Explains each phase of the clinical process for a drug to attain FDA approval
-
Explains several emerging endpoints used in oncology clinical trials
-
Provides an explanation of statistical terms used in clinical trials
-
Takes the learner through the basics of KAM, such as prioritizing, value proposition, strategies, and metrics.